These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16286954)

  • 1. Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm.
    Mikuniya T; Kato Y; Kariyama R; Monden K; Hikida M; Kumon H
    Acta Med Okayama; 2005 Oct; 59(5):209-16. PubMed ID: 16286954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model.
    Mikuniya T; Kato Y; Ida T; Maebashi K; Monden K; Kariyama R; Kumon H
    J Infect Chemother; 2007 Oct; 13(5):285-90. PubMed ID: 17982715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm.
    Kumon H; Ono N; Iida M; Nickel JC
    Antimicrob Agents Chemother; 1995 May; 39(5):1038-44. PubMed ID: 7625785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm.
    Monden K; Ando E; Iida M; Kumon H
    J Infect Chemother; 2002 Sep; 8(3):218-26. PubMed ID: 12373484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents.
    Minardi D; Montanari MP; Tili E; Cochetti I; Mingoia M; Varaldo PE; Muzzonigro G
    J Chemother; 2008 Apr; 20(2):195-201. PubMed ID: 18467245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro].
    Xu Z; Liu F; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):342-4. PubMed ID: 11802985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.
    Cai Y; Fan Y; Wang R; An MM; Liang BB
    J Antimicrob Chemother; 2009 Sep; 64(3):563-6. PubMed ID: 19561148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa.
    Yamada S; Hyo Y; Ohmori S; Ohuchi M
    Chemotherapy; 2007; 53(3):202-9. PubMed ID: 17356268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone.
    Drago L; Mattina R; Legnani D; Romano CL; Vianello E; Ricci C; De Vecchi E
    Int J Immunopathol Pharmacol; 2011; 24(4):1027-35. PubMed ID: 22230408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine.
    Goto T; Nakame Y; Nishida M; Ohi Y
    Urology; 1999 May; 53(5):1058-62. PubMed ID: 10223506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
    Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
    Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of fosfomycin, alone or in combination, against clinical isolates of carbapenem resistant Pseudomonas aeruginosa].
    Gómez-Garcés JL; Gil-Romero Y; Sanz-Rodríguez N; Muñoz-Paraíso C; Regodón-Domínguez M
    Enferm Infecc Microbiol Clin; 2016 Apr; 34(4):228-31. PubMed ID: 26277206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phytoanticipin derivative, sodium houttuyfonate, induces in vitro synergistic effects with levofloxacin against biofilm formation by Pseudomonas aeruginosa.
    Shao J; Cheng H; Wang C; Wang Y
    Molecules; 2012 Sep; 17(9):11242-54. PubMed ID: 22996347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa.
    Abdi-Ali A; Mohammadi-Mehr M; Agha Alaei Y
    Int J Antimicrob Agents; 2006 Mar; 27(3):196-200. PubMed ID: 16459057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin.
    Pallecchi L; Riccobono E; Montagnani F; Di Maggio T; Mantengoli E; Pollini S; Rossolini GM
    J Chemother; 2011 Oct; 23(5):308-9. PubMed ID: 22005066
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa].
    Tani M; Maebashi K; Araake M; Watabe H
    Jpn J Antibiot; 2002 Dec; 55(6):882-5. PubMed ID: 12621742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic assessment of the activity of high-dose (750 mg) levofloxacin, ciprofloxacin, and gatifloxacin against clinical strains of Pseudomonas aeruginosa.
    Garrison MW
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):51-6. PubMed ID: 16368475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G; McKevitt M; Elborn JS; Tunney MM
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected induction of resistant Pseudomonas aeruginosa biofilm to fluoroquinolones by diltiazem: a new perspective of microbiological drug-drug interaction.
    Elkhatib WF; Haynes VL; Noreddin AM
    J Infect Public Health; 2008; 1(2):105-12. PubMed ID: 20701851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.